Asano, Taku; Serruys, Patrick W; Collet, Carlos; Miyazaki, Yosuke; Takahashi, Kuniaki; Chichareon, Ply; Katagiri, Yuki; Modolo, Rodrigo; Tenekecioglu, Erhan; Morel, Marie-Angèle; Garg, Scot; Wykrzykowska, Joanna; Piek, Jan J; Sabate, Manel; Morice, Marie-Claude; Chevalier, Bernard; Windecker, Stephan; Onuma, Yoshinobu (2018). Angiographic late lumen loss revisited: impact on long-term target lesion revascularization. European Heart Journal, 39(36), pp. 3381-3389. Oxford University Press 10.1093/eurheartj/ehy436
|
Text
Angiographic late lumen loss revisited impact on long-term target lesion .pdf - Published Version Available under License Publisher holds Copyright. Download (944kB) | Preview |
Aim
In current device trials, the values of angiographic late lumen loss (LLL) have become extremely low and the relationship between LLL and clinical endpoints has not been recently re-evaluated. The impact of LLL on target lesion revascularization (TLR) in a patient- and study-level analysis of contemporary coronary devices was investigated.
Methods and results
We performed a patient-level meta-analysis of seven randomized controlled trials including 2426 patients treated with first- and second-generation drug-eluting stents (DES) and a study-level meta-analysis of 40 studies including 19 199 patients treated with CE-marked DES. In the patient-level analysis, the probability regression curve showed an exponential relationship between in-stent LLL and 2-year incidence of TLR. The optimal cut-off value of LLL based on Youden's index for 2-year TLR event was 0.50 mm. In the Cox proportional hazard model, LLL >0.50 mm was independently associated with an increased incidence of TLR up to 4 years after angiographic follow-up {adjusted hazard ratio (HR) 6.62 [95% confidence interval (95% CI) 4.67-9.39], P < 0.001}. In the meta-regression analysis of the DES studies, pooled mean value of LLL was as low as 0.23 mm (95% CI 0.20-0.26), and there was a moderate correlation between the 1- and 5-year incidence of TLR and the percentage of the lesions with LLL >0.50 mm (R2 = 0.44, P < 0.001 at 1 year, R2 = 0.40, P < 0.001 at 5 years).
Conclusion
An angiographic LLL ≤0.50 mm was not predictive of the incidence of TLR whereas a LLL >0.50 mm was. Low LLL in contemporary device trials may not be a sufficiently discriminating parameter for the comparative evaluation of devices.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology |
UniBE Contributor: |
Windecker, Stephan |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0195-668X |
Publisher: |
Oxford University Press |
Language: |
English |
Submitter: |
Nadia Biscozzo |
Date Deposited: |
20 Feb 2019 11:43 |
Last Modified: |
05 Dec 2022 15:25 |
Publisher DOI: |
10.1093/eurheartj/ehy436 |
PubMed ID: |
30124834 |
BORIS DOI: |
10.7892/boris.125216 |
URI: |
https://boris.unibe.ch/id/eprint/125216 |